Charlotte's Web Holdings Inc (OTCMKTS: CWBHF) on Track for a Record-Breaking Year - MJ Global Report
Connect with us

CBD Stocks

Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) on Track for a Record-Breaking Year



Charlotte's Web Holdings

Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) is on course for a record-breaking year and continues to live up to much of the expectations as one of the best stocks in the cannabis sector.

Investing in a leader of one of the rapidly growing industries across the globe makes for a significant opportunity. Investing early makes it even better. Charlotte’s stock is a leader in the US CBD market and currently trades on the CSE market in Canada and the OTC in the US.

Charlotte’s Web Holdings Price Analysis

The stock has been climbing up in the charts lately (especially the start of this year) transforming into a leader and one of the market’s most active pot stocks.

CWBHF price today.

It’s fair to say that Charlotte’s price has been relatively up and down in the past month, but it’s now getting the moment up again slowly but surely.

The company is striving to meet the ever-growing CBD product demand, and as it stands, the stock is trading at $15.30. Charlotte Web Holdings is well positioned to get on climbing the ladder given the current strength of the upward momentum.

Charlotte’s Web Holdings Brief Review

Charlotte Web is the market share leader in the hemp-derived CBD extract products. It boasts a robust pipeline of products in tinctures, capsules as well as topical products. The firm produces as well as distributes CBD wellness products to almost 3,700 retail locations.

Last year, the company had 300 acres planted with hemp which is a massive increase from 2017 whereby it had only 70 acres. That significant increase enabled the company to produce more than 675,000 pounds of hemp- 10 times more than in 2017.

Therefore, at that moment, it should be expected that 2019 will be an even better year for the cannabis firm (and early indicators are aggressive already).

Charlotte Web Holdings 2019 Outlook

There’s growing optimism that the company will register robust revenue growth this year. Besides, the company has been consistently profitable going as per the last reported quarterly results.

According to the Q4 2018 results, the company recorded organic consolidated revenue growth of 71% ($21.5 million in amount), which is an increase of 21% from the previous Q4 of 2017.

Furthermore, gross profit increased by 63% to $16.3 million. Full-year revenue was $69.5 million, up by 75% year-over-year. The company ended last year with a balance of $73.4 million as well as working capital of $93.4 million. Interestingly, it has very little debt.

Subsequently, the biggest highlight is the increased inventory meaning the company will have little problem meeting the demand. This year, the primary focus of the firm is all about retail expansion.

The 2019 consensus estimates point out that there will be a 100% increase in revenues (to about $151 million from $70.1 million of last year). Also, the EBITDA is expected to double to $55.8 million from $23.5 million of 2017.

There’s something else that should be noted, too

After evaluating the company, some companies also have recently announced adding CBD products to their stores. For instance, Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) are showing some avenue for growth, hence going forward it looks to be a fragmented industry.

What Next for Charlotte’s Web Holdings

The company is getting popular with its pretty decent loyal customer base that already exists, and with the passing of the Agriculture Improvement Act of 2018, the company will only get even more popular.

When it comes to the CBD stocks, Charlotte’s Web Holdings is undoubtedly one to beat. The company is continuously launching new products as well as ramping up marketing efforts. The company’s market dominance is fierce and last year may have looked as a record-breaking one, but as things stand, 2019 is shaping up nicely to become even better for the most active pot stock.

With the up listing seemingly looking a big move, for investors eyeing opportunities in the marijuana sector, Charlotte’s Web Holdings should be an ideal pick.

For the latest updates on CWBHF and other MJ stocks, sign up below!

Disclosure: We have no position in CWBHF and have not been compensated for this article.

Image courtesy of Pexels

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD Stocks

This Is Why CV Sciences Inc (OTCMKTS: CVSI) Is Rated As A Buy



CV Sciences

CV Sciences Inc (OTCMKTS: CVSI) has lost its spark after a massive surge in the first quarter. The stock is back to where it started the year at, on the upswing losing its momentum. Price action activity has so far remained subdued in a tight $6.30 to $4.20 trading range.

CV Sciences Price Analysis

While the subdued market activity is a point of concern, CV Sciences has continued to fire on all angles when it comes to operational efficiency. Double-digit revenue growth supplemented by gross margin expansion are some of the developments that affirm a company doing well when it comes to execution of its growth strategy.

The Company has also expanded its distribution network into Food, Drug, and Mass channels as the race for accelerated sales growth continues to heat up. Amidst the developments, the stock has continued to edge lower as investors trust continue to edge lower.

CVSI Daily Chart

The recent plunge has exposed the stock to a critical support at the $4.20 level. Above the critical support level, CV Sciences remains supported for further upside action as has been the case in the recent past. Conversely, a breach of the support level could result in the stock plunging further as part of the emerging downtrend.

A rally followed by a close above the $6.30 level, on the other hand, could open the door for the stock to power higher in continuation of…

Continue Reading

CBD Stocks

Why Cannabis Science Inc (OTCMKTS:CBIS) Is Bottoming Out



Cannabis Science

Shares of Cannabis Science Inc (OTCMKTS: CBIS) are looking to bottom out, from one-year lows, after a roller coaster first quarter. The stock has had to contend with wild swings since the start of the year.

After starting the year on a roll and rallying by more than 50%, the stock did succumb to bearish pressure consequently plunging to the $0.03 level.

CBIS Catalysts And Price Analysis

With the stock having taken out the $0.04 level, it might as well have hit the floor and due for a correction higher as a bounce-back play. Some of the catalysts triggering a rally from current lows is the confirmation that the company is expanding its footprint into Canada.

In the recent past, the company has also confirmed the formation iCannabinoid Ambassadors Program. The program is geared towards expanding the company’s footprint and supporting the development of initiatives into new markets.

Cannabis Science has also confirmed plans to expand the scope of its sponsored research in Nigeria to address the potential use of CBD to treat neurological conditions such as Post Traumatic Disorder.

A bounce back from the $0.03 level could as well signal revitalized investors sentiments in the wake of recent developments. After the recent bounce back, the $0.05 is the immediate resistance level standing in the way of the stock edging higher from current lows.

CBIS Daily Chart

Cannabis Science needs to rally and find support above…

Continue Reading

CBD Stocks

CV Sciences Inc (OTCMKTS: CVSI) Is The Best Bet Among CBD Stocks



CV Sciences

CV Sciences Inc (OTCMKTS: CVSI) is one of the best known CBD stocks trading on the OTC Markets. The company makes a popular form of chewing gum and its CBD oil is currently the highest-quality top-selling brand, with an excellent reputation for product safety and efficiency.

So far this year, this popularity has not translated into a top-performing stock. For most of 2019, CVSI has been range-bound, whereas in 2018 we saw the stock run from $1 to $9 in just 4 months. Investors are now asking if we are going to see another explosive move this summer?

CVSI Daily Chart

CVSI Background

First up, here’s a little background info for those of you that aren’t familiar with CVSI. CV Sciences, Inc. operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing novel therapeutics utilizing CBD. The Company’s PlusCBD Oil™ is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada.

Deloitte & Touche LLP As Auditor

The big expectation we have here at MJ Global Report is that CVSI is going to uplist to NASDAQ. This…

Continue Reading

Enter Symbol For Report

MJ Stocks